It is important to consider some caveats about the potential use of MAP4K4 inhibition as a therapeutic agent in cancer, because MAP4K4 has a role in multiple fundamental signaling systems, including NFκB activation, regulation of small GTPases and the Hippo cascade (33). The gene discussed is MAP4K4; the disease is cancer.